World AIDS Day, December 1, 2017 National Aids Trust (NAT)
“World AIDS Day takes place on the 1st December each year. It’s an opportunity for people worldwide to unite in the fight against HIV, to show support for people living with HIV, and to commemorate those who have died from an AIDS-related illness. Founded in 1988, World AIDS Day was the first ever global health day.”
The theme of this year’s World AIDS Day, as promoted by NAT, is “Let’s End It.” This year, NAT is asking everyone to join the fight to end the negative impacts of HIV including isolation, stigma and HIV transmission. According to the World Health Organization (WHO), there were 36.7 million people living with HIV at the end of 2016 and 20.9 million people living with HIV were receiving antiretroviral therapy globally. This year, WHO is advocating for access to safe, effective, quality and affordable HIV services, medicines and and diagnostics other health commodities for all those in need with their slogan “Everybody counts.”
Please visit the World AIDS Day website for more information about the history of the day and how to get involved, support and show solidarity with the millions of people living with HIV.
Human Chimera Research’s Huge (and Thorny) Potential The National Institutes of Health (NIH) reversed policy barring funding from research involving human chimeras (mixtures of human cells with animal embryos) which can yield major human development discoveries.
The minority stress theory suggests that health disparities experienced by gay and bisexual men (GBM) and other sexual minorities can be explained in terms of stigma-related stressors such as discrimination at work, school, religious institutions, communities and families. The unique stressors of an HIV-positive status experienced by GBM, however, has been overlooked within research on minority stress.
Dr. Rendina has been conducting HIV research with GBM for more than ten years. He explained the need to thoroughly test “the role of internalized stigma about sexual orientation, or internalized homophobia, and internalized HIV stigma within a unified model to see whether one or both have an impact on HIV-positive gay or bisexual men.” Although it is already established that GBM are negatively impacted by internalized sexual minority stigma, the purpose of this study was to further explore the impact of HIV-related stressors on the health of GBM.
While bearing the disproportionate burden of HIV/AIDs in the US, African American women also face multi-level stigma at social, community and institutional levels, which is exacerbated by their HIV-positive status.
Dr. Fletcher interviewed 42 African American women with HIV/AIDS living in South Carolina. She found that “HIV/AIDS stigma permeated many dimensions of women’s lives, including the research process.” Using narrative data and the Social Ecological Model, Dr. Fletcher’s findings demonstrate the need for an enhanced understanding of multi-level stigma experienced by HIV-positive African American women to inform innovative and tailored approaches.“Settings that are generally regarded as safe spaces for most individuals are not necessarily safe for HIV-positive African American women due to the intersections of stigma in places where women “live, work, love, play, and pray,” Dr. Fletcher explained.
Although many women in the study identified their homes as safe spaces to complete interviews, several participants completed interviews in Dr. Fletcher’s car to enhance privacy. Dr. Fletcher contends “ethical challenges in the research process emanating from additive, layered stigma can limit the availability of invulnerable research spaces.” Dr. Fletcher shared that her research and training at RETI has offered her a strong foundation to identify and address ethical issues that may arise while engaging communities in the HIV research process.
Please click here for more information on the Fordham University HIV Prevention Research Ethics Training Institute (RETI).